Introduction Sodium-glucose cotransporter 2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) are two classes of glucose-lowering drugs gaining popularity in the treatment ...

Over 60 novel drug candidates are in late-stage clinical trials in China, and these will potentially compete directly with US ...